#ASCO26: Yes, Revolution Medicines' pancreatic cancer data are that good

May 31, 2026 08:06 AM EDTUpdated 09:30 AM R&D Yes, Rev­o­lu­tion Med­i­ci­nes' pan­cre­at­ic can­cer da­ta are that good Lei Lei Wu News Reporter CHICA­GO — When on­col­o­gist Bri­an Wolpin saw the pos­i­tive re­sults from Rev­o­lu­tion Med­i­cines’ piv­otal pan­cre­at­ic can­cer study for the first time, he was ren­dered speech­less, he … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER